Advertisement
Journal Home
Search for

Volume 191, Issue 4, Pages 517-526 (April 2006)


View previous. 16 of 27 View next.

Colon cancer and apoptosis

Sergio Huerta, M.D.Corresponding Author Informationemail address, Emily J. Goulet, B.S., Edward H. Livingston, M.D. (F.A.C.S.)

Received 1 November 2005; received in revised form 28 November 2005

Abstract 

Background

The implementation of new therapeutic options for the management of metastatic colon cancer mandates a revisit to apoptosis and its role in colon cancer tumorigenesis with an emphasis on the mechanisms leading to chemotherapeutic resistance and immune system evasion of colon cancer cells.

Data sources

Literature regarding molecular apoptosis mechanisms and the role of apoptosis in colon cancer progression are reviewed by this article.

Conclusion

Programmed cell death has rapidly emerged as a potential target for cancer treatment at various stages of tumor progression. Chemoprevention, immuno-regulation, and metastasis are prospective targets by which apoptotic mechanisms could be utilized in the prevention and management of tumorigenesis. Understanding how defects in the death receptor pathway of apoptosis permit colon cancer cells to escape the immune system would allow for treatment options whereby the body’s immune system could again recognize and eliminate unwanted cells.

Keywords Caspase , Smac/DIABLO , IAPs , c-FLIP , BAX , TRAIL , p53 , Apc , Fas , Bcl-2 , Bcl-xL , Bak , NFκB , Survivin

Department of Gastrointestinal and Endocrine Surgery, University of Texas Southwestern Medical Center/Veterans Administration North Texas Health Care System, 4500 S Lancaster Rd, Dallas, TX 75216, USA

Corresponding Author InformationCorresponding author. Tel.: +1-214-857-1800; fax: +1-214-857-1891.

PII: S0002-9610(05)00869-X

doi:10.1016/j.amjsurg.2005.11.009


View previous. 16 of 27 View next.

Advertisement